Nr.Numele studiuluiStatusLocatia/Locatiile studiului
1Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (CheckMate 714)Activ, inca nu se recruteazaCentrul Medical Sanador, Bucharest, Romania, 010991CF Clinical Hospital Cluj-Napoca, Cluj-Napoca, Romania, 400015Sf. Nectarie Oncology Center, Craiova, Romania, 200347Institutul Regional de Oncologie Iasi, Iasi, Romania, 700483County Emergency Hospital Suceava, Suceava, Romania, 720237
2Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck Cancer (EAGLE)Activ, inca nu se recruteazaResearch Site, Baia Mare, Romania, 430031Research Site, Brasov, Romania, 500152Research Site, Cluj-Napoca, Romania, 400015Research Site, Cluj, Romania, 400058Research Site, Craiova, Romania, 200347
3Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck CancerActiv, inca nu se recruteazaSC Medisprof SRL, Cluj-Napoca, Cluj, Romania, 400058Centrul de Oncologie Sf. Nectarie SRL, Craiova, Dolj, Romania, 200347SC Oncolab SRL, Craiova, Dolj, Romania, 200385S.C. ONCOCENTER Oncologie Clinica S.R.L., Timisoara, Timis, Romania, 300166Spitalul Clinic Judetean de Urgenta Sibiu, Clinica Oncologie Medicala, Sibiu, Romania, 550245
4Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer (KESTREL)Activ, inca nu se recruteazaResearch Site, Suceava, Romania, 720237
5Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity (IT-MATTERS)Activ, inca nu se recruteazaRegional Institute of Oncology IASI, Iasi, Romania, 700483Spital Clinic Judetean Mures. Targu Mures, Romania, 540072
6Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer (INTERLINK-1)RecruteazaResearch Site Not yet recruiting Constanta, Romania, 900591 Research Site Not yet recruiting Suceava, Romania, 720237
7Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (INDUCE-4)RecruteazaGSK Investigational Site Recruiting Bucuresti, Romania, 021389 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Ingrid Iordan          GSK Investigational Site Recruiting Cluj Napoca, Romania, 400015 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Calin Ioan Cainap          GSK Investigational Site Recruiting Craiova, Romania, 200347 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Michael Schenker          GSK Investigational Site Recruiting Floresti, Romania, 407280 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Andrei Ungureanu          GSK Investigational Site Recruiting Iasi, Romania, 700106 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Constantin Volovat          GSK Investigational Site Recruiting Otopeni, Romania, 075100 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Elena Ciubotaru          GSK Investigational Site Recruiting Suceava, Romania, 720284 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Doina Elena Ganea          GSK Investigational Site Recruiting Targu Mures, Romania, 540156 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Ingrid Oana Mesinschi       
8Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (INDUCE-3)RecruteazaGSK Investigational Site Recruiting Brasov, Romania, 500283 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Mariana Sporis          GSK Investigational Site Recruiting Bucuresti, Romania, 021389 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Ingrid Iordan          GSK Investigational Site Recruiting Cluj Napoca, Romania, 400015 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Calin Ioan Cainap          GSK Investigational Site Recruiting Cluj-Napoca, Romania, 400015 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Tudor Eliade Ciuleanu          GSK Investigational Site Recruiting Constanta, Romania, 900591 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Laura Mazilu          GSK Investigational Site Recruiting Craiova, Romania, 200347 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Michael Schenker          GSK Investigational Site Recruiting Floresti, Romania, 407280 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Andrei Ungureanu          GSK Investigational Site Recruiting Iasi, Romania, 700106 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Constantin Volovat          GSK Investigational Site Recruiting Oradea, Romania, 410469 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Ioana Adriana Puscas          GSK Investigational Site Recruiting Otopeni, Romania, 075100 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Elena Ciubotaru          GSK Investigational Site Recruiting Satu Mare, Romania, 440055 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Loredana Ioana Aracs-Tamas          GSK Investigational Site Recruiting Suceava, Romania, 720284 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Principal Investigator: Doina Elena Ganea       
(Visited 105 times, 1 visits today)